Teva Plans to Divest API Business as Part of Strategic Pivot

By Adriano Marchese Teva Pharmaceutical Industries plans to divest its active-pharmaceutical ingredient business as it looks to pursue new growth...

Related Keywords

Tel Aviv ,Israel ,Richard Francis ,Adriano Marchese ,Teva Pharmaceutical Industries ,Pharmaceutical Industries ,Chief Executive Richard ,Article Normal ,Pharmaceuticals ,Healthcare Life Sciences ,Generic Biosimilar Drugs ,Corporate Strategy Planning ,Ownership Changes ,Corporate Actions ,Corporate Industrial News ,Divestments ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Teva Tv ,Teva ,Corporate Strategy ,Planning ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,Generic ,Biosimilar Drugs ,